The phrase "access for developing countries" is correct and usable in written English.
It can be used when discussing the availability or provision of resources, opportunities, or services specifically aimed at developing nations.
Example: "The conference focused on improving access for developing countries to essential healthcare resources."
Alternatives: "opportunities for developing nations" or "accessibility for emerging economies."
In March, EU leaders said they were committed to a multilateral agenda for trade and development: promoting market access for developing countries through the EU's generalised system of preferences (GSP) and economic partnership agreements (EPAs); sustainable development through liberalisation of green goods and services; and more targeted aid for trade.
The United States already provides more than $20 billion in duty-free access for developing countries.
But he has so far rejected demands to take immediate steps to increase market access for developing countries.
They also raised the issue of the cost of Internet access for developing countries struggling to close a daunting technology gap with richer countries.
When it comes to cloud computing, providing the most computing power for the lowest cost could mean increased internet access for developing countries.
But despite the round's mission to improve market access for developing countries' exports, the share of global exports originating from America and Europe has also grown (see chart 2 below).
Access for developing country exports to developed country markets on preferential terms has been a long standing component of multilateral trading arrangements.
When will you start reducing agricultural subsidies so as to provide market access for developing country agricultural products? 5.
It also results in unpredictable market access conditions for developing countries.
Access to increased information can contribute to cost savings and potentially increase the access to medicines for developing countries.
This article discusses in what ways medicine price information mechanisms can contribute to increased price transparency and how this may affect access to medicines for developing countries.
